In this issue of the Revista Brasileira de Terapia Intensiva, Rios et al.( demonstrate the effects of volume
replacement with hypertonicsaline solution (HSS) on hepatic cytokine production and
expression of heat-shock proteins and apoptotic proteins in an animal model of acute
pancreatitis. HSS down-regulated liver cytokine production and HSP60 expression in a more
robust manner when compared to normal saline solution.More than 30 years have passed since the first description of HSS as a resuscitation
solution in hemorrhagic shock.( HSS can
exert its beneficial effects by mobilizing fluids from intracellular to extracellular
compartments and by improving myocardial contractility and microcirculatory
flow.( In addition, it may have
immunomodulatory effects.( Thus, the
original rationale based on its osmotic effect that enables small volume resuscitation in
hypovolemic shock( and decreases brain
edema after traumatic brain injury( may
be too simplistic. The results presented by Rios et al.( add to previous demonstrations of benefit from HSS on
several different aspects of inflammation and organ function in pre-clinical models of
systemic inflammatory response syndrome (SIRS) and sepsis.( However, human trials have failed to provide convincing
evidence of efficacy.( Clearly this
potential needs to be examined further, particularly as it is cheap and widely available,
but we should wait until more robust clinical data are available.